ImmuPharma chairman more optimistic on results for its Lupuzor drug – May 2018

29th May 2018 - 7:10 pm

Tim McCarthy, chairman of ImmuPharma PLC (LON:IMM) tells Proactive that there is a strong indication that in certain populations of lupus patients, its Lupuzor drug works very effectively.  McCarthy was talking after a deeper dive into the data generated…



Share this article